Article Versions Notes

Valeriani M, Di Staso M, Facondo G, Vullo G, De Sanctis V, Gravina GL, di Genesio Pagliuca M, Osti MF, Bonfili P. Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results. Journal of Clinical Medicine. 2022; 11(16):4783. https://doi.org/10.3390/jcm11164783

Valeriani, Maurizio, Mario Di Staso, Giuseppe Facondo, Gianluca Vullo, Vitaliana De Sanctis, Giovanni Luca Gravina, Milena di Genesio Pagliuca, Mattia Falchetto Osti, and Pierluigi Bonfili. 2022. "Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results" Journal of Clinical Medicine 11, no. 16: 4783. https://doi.org/10.3390/jcm11164783

Valeriani, M., Di Staso, M., Facondo, G., Vullo, G., De Sanctis, V., Gravina, G. L., di Genesio Pagliuca, M., Osti, M. F., & Bonfili, P. (2022). Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results. Journal of Clinical Medicine, 11(16), 4783. https://doi.org/10.3390/jcm11164783